PCIB — PCI Biotech Holding ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK13.81m
- NOK0.48m
- NOK6.74m
Annual cashflow statement for PCI Biotech Holding ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -72.2 | -88.4 | -55.1 | -20.3 | -16.4 |
| Depreciation | |||||
| Non-Cash Items | -2.11 | 15.5 | -1.41 | 2 | 0.885 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.25 | 2.04 | -8.94 | 2.97 | 1.47 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -77.4 | -68.3 | -59 | -15 | -13.8 |
| Capital Expenditures | -3.92 | -0.341 | 0 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -3.92 | -0.341 | 0 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.352 | -0.673 | -0.678 | -0.442 | -0.357 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -73.1 | -71.8 | -59.5 | -15.4 | -14.1 |